4 March 2021 - Ofev is the first treatment available in Canada for chronic fibrosing interstitial lung diseases with a progressive ...
2 March 2021 - Approval is based on the Phase 3 ASPEN trial of Brukinsa compared to ibrutinib. ...
2 March 2021 - Openness and transparency are key to building confidence in COVID-19 vaccines. Today, EMA and Health Canada ...
26 February 2021 - Canada's regulator estimates vaccine's efficacy at 62.1 per cent. ...
25 February 2021 - The first and only anti-CGRP treatment with dual indications. ...
25 February 2021 - Medexus Pharmaceuticals announced today that it has initiated the commercial launch of Gleolan in Canada, which had ...
24 February 2021 - Prince Edward Island lists Skyrizi on its Pharmacare Formulary effective 22 February 2021. ...
24 February 2021 - Verity-BCG bladder cancer treatment available for Canadian patients in the spring. ...
23 February 2021 - Dupixent is the only biologic medicine approved to treat atopic dermatitis for this patient population. ...
19 February 2021 - Ontario’s Health Minister Christine Elliott says life-saving cystic fibrosis medications that are inching their way through ...
18 February 2021 - Health Canada is not yet ready to make a decision about approving the COVID-19 vaccine from ...
18 February 2021 - Viatris announced today that Health Canada has approved Hulio, and product is now available in Canada. ...
18 February 2021 - Biosimilars offer patients access to affordable, meaningful medicines ...
16 February 2021 - Active negotiations have also begun with the pan-Canadian Pharmaceutical Alliance for reimbursement of Vascepa by publicly funded ...
17 February 2021 - First approved treatment for adult and paediatric patients with long-chain fatty acid oxidation disorders in Canada. ...